BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CEACAM5, CEA AND Prognosis
909 results:

  • 1. Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer.
    Xie H; Wei L; Wang Q; Tang S; Gan J
    Sci Rep; 2024 May; 14(1):10057. PubMed ID: 38698172
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
    Zhang Q; Wang L; Sun R; Gao J; Liu T
    Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]    [Full Text] [Related]  

  • 4. Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation.
    Li F; Liu L; Feng Q; Wang X; Liu F; Yang L; Miao L; Wang W; Ji G; Yu C
    World J Surg Oncol; 2024 Apr; 22(1):107. PubMed ID: 38644507
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis.
    Zeng H; Xue X; Chen D; Zheng B; Liang B; Que Z; Xu D; Wang X; Lin S
    Int J Colorectal Dis; 2024 Apr; 39(1):54. PubMed ID: 38639915
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
    Chen H; Wang C; Chen Z; Huang T; Lin Y; Chen J; Zhang B; He X
    BMC Cancer; 2024 Apr; 24(1):433. PubMed ID: 38589842
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
    Tan Y; Liu R; Xue JW; Feng Z
    Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
    BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The oncologic outcome and prognostic factors for solitary colorectal liver metastasis after liver resection.
    Hsu YJ; Chern YJ; Wu ZE; Yu YL; Liao CK; Tsai WS; You JF; Lee CW
    J Gastrointest Surg; 2024 Mar; 28(3):267-275. PubMed ID: 38445919
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CT-guided radioactive
    Song M; Zhou X; Hou R; Sigdel M; Liu Y; Zhang C; Xu K; Han X; Jiao D
    BMC Cancer; 2024 Feb; 24(1):265. PubMed ID: 38403626
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer.
    Kamada T; Ohdaira H; Takahashi J; Aida T; Nakashima K; Ito E; Hata T; Yoshida M; Eto K; Suzuki Y
    Sci Rep; 2024 Feb; 14(1):4192. PubMed ID: 38378762
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
    Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
    Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer.
    Huang BL; Wei LF; Lin YW; Huang LS; Qu QQ; Li XH; Chu LY; Xu YW; Wang WD; Peng YH; Wu FC
    Sci Rep; 2024 Jan; 14(1):1839. PubMed ID: 38246959
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients.
    Mahmoud AA; Mohamed HO; Shehata MR; Refae AAS; Abd El Salam MH; Seddik MI
    Egypt J Immunol; 2024 Jan; 31(1):106-115. PubMed ID: 38224275
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk Factors of Venous Thromboembolism in Inpatients With colorectal cancer in China.
    Chen F; Sun Y; Zhang C; Li L; Du Y; Zhou M; Cheng W
    Clin Appl Thromb Hemost; 2023; 29():10760296231221133. PubMed ID: 38105233
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.
    Kitano Y; Ono Y; Kobayashi K; Oba A; Sato T; Ito H; Inoue Y; Shinozaki E; Yamaguchi K; Saiura A; Baba H; Takahashi Y
    HPB (Oxford); 2024 Feb; 26(2):282-290. PubMed ID: 37985325
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The clinical value of a nomogram constructed from cea, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.
    Wang K; Ma L; Chen L; Jiang Y; Liu N; Cai J; Zhang Y
    Cancer Biomark; 2023; 38(4):537-549. PubMed ID: 37980649
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic Potential of Nectin Expressions in colorectal cancer: An Exploratory Study.
    Kobecki J; Gajdzis P; Mazur G; Chabowski M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A large-scale study integrating nutritional indicators and clinicopathological parameters to evaluate prognosis, follow-up, and postoperative chemotherapy decisions in rectal cancer patients.
    Yu Y; Wu J; Wu H; Wang Z; Wu S; Hong L; Xu B; Shao L
    Support Care Cancer; 2023 Nov; 31(12):686. PubMed ID: 37945781
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 46.